The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
P-015 YI Low-Dose Naltrexone Therapy Improves Active Ulcerative Colitis
Inflam Bowel Dis
01 December 2013
https://academic.oup.com/ibdjournal/search-results?page=1&q=Low-Dose%20Naltrexone%20Therapy%20Improves%20Active%20Ulcerative%20Colitis&fl_SiteID=6136&SearchSourceType=1&allJournals=1
Tu1365 Low Dose Naltrexone in the Treatment of Crohn's Disease: A Case Series
Gastroenterology
April 2015
http://www.gastrojournal.org/article/S0016-5085(15)32952-8/abstract
Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial
Dig Dis Sci
July 2011
https://pubmed.ncbi.nlm.nih.gov/21380937/
Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patient
Inflamm Bowel Dis
September 2010
https://academic.oup.com/ibdjournal/article/16/9/1457/4628412
Low-dose naltrexone therapy improves active Crohn's disease
Am J Gastroenterol
April 2007
https://pubmed.ncbi.nlm.nih.gov/17222320/
Objectives: Endogenous opioids and opioid antagonists have been shown to play a role in healing and repair of tissues. In an open-labeled pilot prospective trial, the safety and efficacy of low-dose naltrexone (LDN), an opioid antagonist, were tested in patients with active Crohn's disease.
Psychoneuroimmunological approach to gastrointestinal related pain
Scand J Pain
October 2017
https://pubmed.ncbi.nlm.nih.gov/29122501/
The Use of Naltrexone in Low Doses Beyond the Approved Indication [Internet]
Report from Norwegian Knowledge Centre for the Health Services
April 2015
https://pubmed.ncbi.nlm.nih.gov/28510411/
The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders
Pharmacotherapy
March 2018
https://pubmed.ncbi.nlm.nih.gov/29377216/
Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
J Transl Med
09 March 2018
https://pubmed.ncbi.nlm.nih.gov/29523156/
Low dose naltrexone for induction of remission in Crohn's disease
Cochrane Database Syst Rev
01 April 2018
https://pubmed.ncbi.nlm.nih.gov/29607497/